| Utility: Peptides and combination of peptides for use in immunotherapy against various tumors Filling date: 8 Sep 2025 Issue date: 6 Sep 2022 | 18 Mar 2022 | 6 Sep 2022 |
| Utility: Immunotherapy with B*08 restricted peptides and combination of peptides against cancers and related methods Filling date: 8 Sep 2025 Issue date: 6 Sep 2022 | 24 Sep 2021 | 6 Sep 2022 |
| Utility: Peptides and combination of peptides for use in immunotherapy against various tumors Filling date: 8 Sep 2025 Issue date: 6 Sep 2022 | 27 Aug 2021 | 6 Sep 2022 |
| Utility: Peptides and combination of peptides for use in immunotherapy against various cancers Filling date: 8 Sep 2025 Issue date: 6 Sep 2022 | 5 Dec 2019 | 6 Sep 2022 |
| Utility: Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers Filling date: 8 Sep 2025 Issue date: 30 Aug 2022 | 11 Feb 2022 | 30 Aug 2022 |
| Utility: Peptides and combination thereof for use in the immunotherapy against cancers Filling date: 8 Sep 2025 Issue date: 30 Aug 2022 | 10 Apr 2018 | 30 Aug 2022 |
| Utility: Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers Filling date: 8 Sep 2025 Issue date: 16 Aug 2022 | 4 Feb 2022 | 16 Aug 2022 |
| Utility: Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers Filling date: 8 Sep 2025 Issue date: 16 Aug 2022 | 28 Jan 2022 | 16 Aug 2022 |
| Utility: Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers Filling date: 8 Sep 2025 Issue date: 16 Aug 2022 | 21 Jan 2022 | 16 Aug 2022 |
| Utility: Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers Filling date: 8 Sep 2025 Issue date: 16 Aug 2022 | 23 Dec 2021 | 16 Aug 2022 |
| Utility: Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers Filling date: 8 Sep 2025 Issue date: 9 Aug 2022 | 7 Jan 2022 | 9 Aug 2022 |
| Utility: Peptides and combination of peptides for use in immunotherapy against various tumors Filling date: 8 Sep 2025 Issue date: 9 Aug 2022 | 27 Aug 2021 | 9 Aug 2022 |
| Utility: Peptides and combination of peptides for use in immunotherapy against various tumors Filling date: 8 Sep 2025 Issue date: 9 Aug 2022 | 13 Aug 2021 | 9 Aug 2022 |
| Utility: Peptides and combination of peptides for use in immunotherapy against various tumors Filling date: 8 Sep 2025 Issue date: 9 Aug 2022 | 30 Jul 2021 | 9 Aug 2022 |
| Utility: Peptides and combination of peptides for use in immunotherapy against various tumors Filling date: 8 Sep 2025 Issue date: 9 Aug 2022 | 23 Jul 2021 | 9 Aug 2022 |
| Utility: Peptides and combination of peptides for use in immunotherapy against hepatocellular carcinoma (HCC) and other cancers Filling date: 8 Sep 2025 Issue date: 9 Aug 2022 | 12 Mar 2018 | 9 Aug 2022 |
| Utility: Peptides and combination of peptides for use in immunotherapy against esophageal cancer and other cancers Filling date: 8 Sep 2025 Issue date: 2 Aug 2022 | 17 Dec 2021 | 2 Aug 2022 |
| Utility: Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers Filling date: 8 Sep 2025 Issue date: 2 Aug 2022 | 12 Nov 2021 | 2 Aug 2022 |
| Utility: Uterine cancer treatments Filling date: 8 Sep 2025 Issue date: 19 Jul 2022 | 12 Nov 2019 | 19 Jul 2022 |
| Utility: Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers Filling date: 8 Sep 2025 Issue date: 12 Jul 2022 | 18 Nov 2021 | 12 Jul 2022 |
| Utility: Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers Filling date: 8 Sep 2025 Issue date: 12 Jul 2022 | 5 Nov 2021 | 12 Jul 2022 |
| Utility: Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers Filling date: 8 Sep 2025 Issue date: 12 Jul 2022 | 29 Oct 2021 | 12 Jul 2022 |
| Utility: Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers Filling date: 8 Sep 2025 Issue date: 5 Jul 2022 | 2 Jul 2021 | 5 Jul 2022 |
| Utility: Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers Filling date: 8 Sep 2025 Issue date: 28 Jun 2022 | 17 Sep 2021 | 28 Jun 2022 |
| Utility: Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers Filling date: 8 Sep 2025 Issue date: 28 Jun 2022 | 10 Sep 2021 | 28 Jun 2022 |
| Utility: Peptides and combination of peptides for use in immunotherapy against various tumors Filling date: 8 Sep 2025 Issue date: 21 Jun 2022 | 6 Aug 2021 | 21 Jun 2022 |
| Utility: Peptides and combination of peptides for use in immunotherapy against various tumors Filling date: 8 Sep 2025 Issue date: 21 Jun 2022 | 30 Jul 2021 | 21 Jun 2022 |
| Utility: Peptides and combination of peptides for use in immunotherapy against esophageal cancer and other cancers Filling date: 8 Sep 2025 Issue date: 14 Jun 2022 | 10 Dec 2021 | 14 Jun 2022 |
| Utility: Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers Filling date: 8 Sep 2025 Issue date: 14 Jun 2022 | 17 Sep 2021 | 14 Jun 2022 |
| Utility: Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers Filling date: 8 Sep 2025 Issue date: 7 Jun 2022 | 2 Sep 2021 | 7 Jun 2022 |
| Utility: Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers Filling date: 8 Sep 2025 Issue date: 31 May 2022 | 2 Sep 2021 | 31 May 2022 |
| Utility: Peptides and combination of peptides for use in immunotherapy against various tumors Filling date: 8 Sep 2025 Issue date: 17 May 2022 | 1 Oct 2021 | 17 May 2022 |
| Utility: Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC and other cancers Filling date: 8 Sep 2025 Issue date: 10 May 2022 | 15 Oct 2021 | 10 May 2022 |
| Utility: Immunotherapy against several tumors including gastrointestinal and gastric cancer Filling date: 8 Sep 2025 Issue date: 12 Apr 2022 | 1 Oct 2021 | 12 Apr 2022 |
| Utility: Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers Filling date: 8 Sep 2025 Issue date: 5 Apr 2022 | 16 Jul 2021 | 5 Apr 2022 |
| Utility: Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers Filling date: 8 Sep 2025 Issue date: 22 Mar 2022 | 9 Jul 2021 | 22 Mar 2022 |
| Utility: Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers Filling date: 8 Sep 2025 Issue date: 22 Mar 2022 | 9 Jul 2021 | 22 Mar 2022 |
| Utility: Peptides and combination of peptides for use in immunotherapy against epithelial ovarian cancer and other cancers Filling date: 8 Sep 2025 Issue date: 22 Mar 2022 | 30 Apr 2021 | 22 Mar 2022 |
| Utility: Immunotherapy against several tumors including gastrointestinal and gastric cancer Filling date: 8 Sep 2025 Issue date: 15 Mar 2022 | 24 Sep 2021 | 15 Mar 2022 |
| Utility: Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers Filling date: 8 Sep 2025 Issue date: 1 Mar 2022 | 16 Jul 2021 | 1 Mar 2022 |
| Utility: Peptides and combination of peptides for use in immunotherapy against CLL and other cancers Filling date: 8 Sep 2025 Issue date: 1 Mar 2022 | 14 May 2021 | 1 Mar 2022 |
| Utility: A*03 restricted peptides for use in immunotherapy against cancers and related methods Filling date: 8 Sep 2025 Issue date: 15 Feb 2022 | 2 Jul 2021 | 15 Feb 2022 |
| Utility: Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers Filling date: 8 Sep 2025 Issue date: 15 Feb 2022 | 11 Jun 2021 | 15 Feb 2022 |
| Utility: Peptides and combination of peptides for use in immunotherapy against epithelial ovarian cancer and other cancers Filling date: 8 Sep 2025 Issue date: 15 Feb 2022 | 30 Apr 2021 | 15 Feb 2022 |
| Utility: Peptides and combination of peptides for use in immunotherapy against various cancers Filling date: 8 Sep 2025 Issue date: 1 Feb 2022 | 4 Jun 2021 | 1 Feb 2022 |
| Utility: Peptides and combination of peptides for use in immunotherapy against various cancers Filling date: 8 Sep 2025 Issue date: 1 Feb 2022 | 21 May 2021 | 1 Feb 2022 |
| Utility: T cell receptors and immune therapy using the same against PRAME positive cancers Filling date: 8 Sep 2025 Issue date: 1 Feb 2022 | 22 Mar 2018 | 1 Feb 2022 |
| Utility: Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers Filling date: 8 Sep 2025 Issue date: 25 Jan 2022 | 1 Jun 2020 | 25 Jan 2022 |
| Utility: Peptides and combination of peptides for use in immunotherapy against various cancers Filling date: 8 Sep 2025 Issue date: 18 Jan 2022 | 28 May 2021 | 18 Jan 2022 |
| Utility: Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers Filling date: 8 Sep 2025 Issue date: 4 Jan 2022 | 17 Jun 2021 | 4 Jan 2022 |
